Molecular dynamics simulations suggest evodiamine’s binding to NF-κB’s ordered domain, highlighting its therapeutic potential for UC and CRC by suppressing inflammation and regulating cytokine secretion [136]. Here, NFKB1 is linked to colorectal carcinoma.